COST-EFFECTIVENESS AND BUDGET IMPACT OF INTERFERON-FREE DIRECT-ACTING ANTIVIRAL (DAA)-BASED REGIMENS FOR CHRONIC HEPATITIS C TREATMENT. THE FRENCH CASE

被引：0
|
作者：
Deuffic-Burban, S. [1 ,2 ]
Obach, D. [1 ]
Canva, V. [3 ]
Pol, S. [4 ,5 ]
Roudot-Thoraval, F. [6 ]
Dhumeaux, D. [7 ]
Mathurin, P. [2 ,3 ]
Yazdanpanah, Y. [1 ,8 ]
机构：
[1] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, Paris, France
[2] Univ Lille, INSERM, Lille Inflammat Res Int, CHU Lille,LIRIC,U995, Villeneuve Dascq, France
[3] CHRU Lille, Hop Huriez, Serv Malad Appareil Digestif & Nutr, Lille, France
[4] Grp Hosp Cochin Hotel Dieu, Unite Hepatol, Paris, France
[5] Univ Paris 05, INSERM, U1016, Paris, France
[6] Hop Henri Mondor, Serv Sante Publ, Creteil, France
[7] Hop Henri Mondor, INSERM, U955, Creteil, France
[8] Hop Bichat Claude Bernard, Serv Malad Infect & Trop, Paris, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00793-5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-434
引用
收藏
页码：S470 / S471
页数：2
相关论文
共 50 条
  • [21] Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C
    Honma, Yuichi
    Shibata, Michihiko
    Morino, Kahori
    Koya, Yudai
    Hayashi, Tsuguru
    Ogino, Noriyoshi
    Kusanaga, Masashi
    Oe, Shinji
    Miyagawa, Koichiro
    Abe, Shintaro
    Tabaru, Akinari
    Harada, Masaru
    DIGESTIVE DISEASES AND SCIENCES, 2023, 68 (02) : 685 - 698
  • [22] Economic evaluation of pan-genotypic generic direct-acting antiviral regimens for treatment of chronic hepatitis C in Iran: a cost-effectiveness study
    Gholamhoseini, Mohammad Tasavon
    Sharafi, Heidar
    Borba, Helena H. L.
    Alavian, Seyed Moayed
    Sabermahani, Asma
    Hajarizadeh, Behzad
    BMJ OPEN, 2022, 12 (06):
  • [23] VIRAL HEPATITIS Cost-effectiveness of direct-acting antivirals for chronic hepatitis C
    Sroczynski, Gaby
    Siebert, Uwe
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (10) : 572 - 574
  • [24] Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C
    Yuichi Honma
    Michihiko Shibata
    Kahori Morino
    Yudai Koya
    Tsuguru Hayashi
    Noriyoshi Ogino
    Masashi Kusanaga
    Shinji Oe
    Koichiro Miyagawa
    Shintaro Abe
    Akinari Tabaru
    Masaru Harada
    Digestive Diseases and Sciences, 2023, 68 : 685 - 698
  • [25] Electrocardiographic alterations during interferon-free direct-acting antiviral therapy for hepatitis C virus
    Garcia-Arribas, D.
    Lopez-Garcia, O. N.
    Olmos, C.
    Higueras Nafria, J.
    Devesa Medina, M. J.
    Cuenca Alarcon, F.
    Izquierdo Rubio, S.
    Maroto Castellanos, M.
    Rey Diaz-Rubio, E.
    EUROPEAN HEART JOURNAL, 2017, 38 : 578 - 578
  • [26] SUSTAINED VIROLOGIC RESPONSE AMONG PATIENTS WITH GENOTYPE 1 HEPATITIS C AND TREATED WITH INTERFERON-FREE DIRECT-ACTING ANTIVIRAL REGIMENS
    Hull, M.
    Puenpatom, A.
    McPheeters, J.
    Schwebke, K.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S798 - S798
  • [27] Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong
    X. Li
    N. S. Chan
    A. W. Tam
    I. F. N. Hung
    E. W. Chan
    European Journal of Clinical Microbiology & Infectious Diseases, 2017, 36 : 1801 - 1809
  • [28] Budget impact and cost-effectiveness analyses of direct-acting antivirals for chronic hepatitis C virus infection in Hong Kong
    Li, X.
    Chan, N. S.
    Tam, A. W.
    Hung, I. F. N.
    Chan, E. W.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2017, 36 (10) : 1801 - 1809
  • [29] Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)
    David R. Walker
    Marcos C. Pedrosa
    Shivaji R. Manthena
    Nikil Patel
    Steven E. Marx
    Advances in Therapy, 2015, 32 : 1117 - 1127
  • [30] Early View of the Effectiveness of New Direct-Acting Antiviral (DAA) Regimens in Patients with Hepatitis C Virus (HCV)
    Walker, David R.
    Pedrosa, Marcos C.
    Manthena, Shivaji R.
    Patel, Nikil
    Marx, Steven E.
    ADVANCES IN THERAPY, 2015, 32 (11) : 1117 - 1127
12345